The Trade Desk Reports Third Quarter Financial Results
Nov 09, 2017 21:01 pm UTC| Business
LOS ANGELES, Nov. 09, 2017 -- The Trade Desk, Inc. (NASDAQ:TTD), a provider of a global technology platform for buyers of advertising, today announced financial results for its third quarter ended September 30, 2017. ...
Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates
Nov 09, 2017 21:01 pm UTC| Business
Received FDA Clearance of IND Application for XMT-1536, a First-in-Class Dolaflexin® Antibody Drug Conjugate Targeting NaPi2b XMT-1522 Phase 1 Trial Continues Enrollment of Patients with Advanced Tumors Expressing HER2 ...
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results
Nov 09, 2017 21:01 pm UTC| Business
ANN ARBOR, Mich., Nov. 09, 2017 -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim...
Ideal Power Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:01 pm UTC| Business
AUSTIN, Texas, Nov. 09, 2017 -- Ideal Power Inc. (NASDAQ:IPWR), an innovative power conversion technology company, reported results for the third quarter ending September 30, 2017. Key Third Quarter 2017 and...
Park City Group Reports Fiscal First Quarter 2018 Results
Nov 09, 2017 21:01 pm UTC| Business
Revenue Increased 12%, as Efforts Focused on Record ReposiTrak Backlog Operating Cash Flow Increased to $1.1 Million Leading to Record Cash Balance Management Reiterates Fiscal 2018 Revenue Growth Within Annual Target of...
Stemline Therapeutics Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:01 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial results for the...
Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 09, 2017 21:01 pm UTC| Business
Initiated a Phase 2 clinical trial with NasoVAX vaccine with initial data expected in first quarter 2018 Completed enrollment in its Phase 1 HepTcell clinical trial with data expected in fourth quarter 2017 Conference...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update